Provided by Tiger Trade Technology Pte. Ltd.

Core Assets of Southward Funds

1,020.492
-2.118-0.21%
Number of Gainers:17
Number of Losers:45
Number of Flat:5
PE:- -
High:1,022.907
Open:1,021.070
Low:1,012.159
Close:1,022.611
Volume:1.35B
Turnover:34.26B
Market Cap:13.87T
Float Cap:12.90T

Loading ...

Yadea Group Holdings H1 Net Income Attributable RMB 1,200.9 Million

THOMSON REUTERS
·
Aug 25

Hong Kong Stock Market Flash | CR BLDG MAT TEC (01313) Drops Nearly 3% Before Noon, Swings to Loss in H1 Results as Cement Sales Volume Declines

Stock News
·
Aug 25

HK-Listed WuXi XDC Hits 10-Month Peak on Solid First-Half Results

Reuters
·
Aug 25

Xiaomi's Triple Chip Launch: A Decisive Bet on AI That Could Pay Off Big

Deep News
·
Aug 25

Hong Kong Stocks in Focus: CRO Sector Rallies as Offshore CXO Leaders Post Strong Results

Stock News
·
Aug 25

The Bell Rings, $170 Billion Vanishes: Why Isn't Wang Xingxing Smiling?

Deep News
·
Aug 25

SMOORE INTL Awards 2.2 Million Incentive Shares to Key Participants

Deep News
·
Aug 25

Asian Growth Companies With Strong Insider Ownership

Simply Wall St.
·
Aug 25

Transcenta Holding Announces Extraordinary General Meeting

Reuters
·
Aug 25

Tencent (SEHK:700) Stock Still Looks Undervalued After Recent Weakness

Simply Wall St.
·
Aug 25

Xiaomi Japan to Raise Prices on Multiple Smartphones and Tablets by Up to One-Third Starting September

Deep News
·
Aug 24

Xiaomi's 18 Fold With New Zircon O3 Chip Set to Launch in September

Deep News
·
Aug 24

SMOORE INTL Grants 3.67 Million Share Options to Eligible Staff

Stock News
·
Aug 24

Global TV Market Sees 2% Shipment Growth in First Half of 2026, Led by World Cup Demand and Cost-Driven Pull-Forward

Stock News
·
Aug 24

Why Did AIA's Record-Breaking H1 Profit of $4.294 Billion Fail to Impress the Market?

Deep News
·
Aug 24

Chinese Drugmaker Wuxi XDC's First-Half Revenue Rises on Project Expansion, Acquisition

Reuters
·
Aug 24

WuXi XDC FY26 H1 Net Profit Rises 9.7% to RMB 818 Million; Revenue Climbs 37% to RMB 3.7 Billion

Reuters
·
Aug 24

Nomura Adjusts Sino Biopharmaceutical's Price Target to HK$8.67 From HK$8.26, Keeps at Buy

MT Newswires Live
·
Aug 24

Nomura Adjusts Li Ning's Price Target to HK$13.80 From HK$16, Keeps at Neutral

MT Newswires Live
·
Aug 24

Xiaomi-W Executes Share Buyback Valued at Approximately HK$50.78 Million

Stock News
·
Aug 24